IQVIA Risk-Based Monitoring (RBM) enhances clinical trial oversight by using AI/ML, automation, and advanced analytics to identify risks early, improve safety, and cut costs. Studies using RBM lock databases 12.5 days faster, achieve up to 25% cost savings, and reduce SDV backlog by 31% compared to traditional methods. Patient safety improves as 67% of queries trigger database updates, 74% tied to safety. Key features include risk management, site risk monitoring, subject data surveillance, and intuitive dashboards with automated alerts. RBM delivers real-time insights, enabling smarter decisions and faster corrective actions.

Join for free to read